6 results for author:"Bezeaud A." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis. Pasmant E., de Beauvoir C., Plessier A., Labreuche J., Bezeaud A. Thromb. Res. 126:e134-6(2010) · Mapped (9) |
| A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin. d'Audigier C., Pasmant E., Bournier O., Laurian Y., Guillin M.C., Bezeaud A. Haematologica 93:799-800(2008) · Mapped (8) |
| A critical role for Gly25 in the B chain of human thrombin. Akhavan S., Miteva M.A., Villoutreix B.O., Venisse L., Peyvandi F., Mannucci P.M., Guillin M.C., Bezeaud A. J. Thromb. Haemost. 3:139-145(2005) · Mapped (8) |
| Inhibition of thrombin-catalyzed factor V activation by bothrojaracin. Arocas V., Lemaire C., Bouton M.C., Bezeaud A., Bon C., Guillin M.-C., Jandrot-Perrus M. Thromb. Haemost. 79:1157-1161(1998) · UniProtKB (2) |
| Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille). Bezeaud A., Miyata T., Helley D., Zeng Y.Z., Kato H., Aillaud M.F., Juhan-Vague I., Guillin M.C. Eur. J. Biochem. 234:140-147(1995) · UniProtKB (1) |
| Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. Miyata T., Aruga R., Umeyama H., Bezeaud A., Guillin M.-C., Iwanaga S. Biochemistry 31:7457-7462(1992) · UniProtKB (1) |